Clearside Biomedical, Inc. (CLSD) Financials

CLSD Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 11.6 million 65.6 million
June 30, 2025 15.3 million 64.1 million
March 31, 2025 19.7 million 65.6 million
Dec. 31, 2024 25.1 million 64.0 million

CLSD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 -5.5 million 746000
June 30, 2025 -4.7 million 694000
March 31, 2025 -5.8 million 721000
Dec. 31, 2024 -5.7 million 1.2 million

CLSD Net Income

No data available :(

CLSD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 6.8 million 62000 446000
June 30, 2025 9.4 million 152000 533000
March 31, 2025 13.6 million 53.7 million 619000
Dec. 31, 2024 20.0 million 52.1 million 703000

CLSD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 5.2 million
June 30, 2025 5.2 million
March 31, 2025 5.1 million
Dec. 31, 2024 5.1 million

CLSD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 9000 2.9 million 4.3 million -
June 30, 2025 - 1.6 million 2.5 million -
March 31, 2025 9000 4.5 million 2.8 million -
Dec. 31, 2024 444000 4.2 million 3.1 million -

CLSD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 201000 -
June 30, 2025 492000 84000
March 31, 2025 2.3 million 248000
Dec. 31, 2024 306000 149000

CLSD Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CLSD

Price: $0.41

52 week price:
0.37
17.10

Earnings Per Share: -5.11 USD

P/E Ratio: -0.20

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 411200

Ebitda: -18.1 million

Market Capitalization: 5.2 million

Links: